Sharkey, Howes & Javer’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-800
Closed -$78K 122
2019
Q2
$78K Hold
800
0.04% 94
2019
Q1
$73K Hold
800
0.03% 96
2018
Q4
$73K Hold
800
0.05% 92
2018
Q3
$79K Hold
800
0.04% 95
2018
Q2
$68K Hold
800
0.04% 90
2018
Q1
$64K Hold
800
0.04% 80
2017
Q4
$65K Sell
800
-649
-45% -$52K 0.04% 77
2017
Q3
$112K Buy
1,449
+449
+45% +$37.3K 0.06% 61
2017
Q2
$89K Sell
1,000
-100
-9% -$8.43K 0.05% 68
2017
Q1
$89K Hold
1,100
0.05% 66
2016
Q4
$78K Hold
1,100
0.05% 73
2016
Q3
$95K Hold
1,100
0.06% 60
2016
Q2
$83K Hold
1,100
0.05% 73
2016
Q1
$83K Hold
1,100
0.06% 69
2015
Q4
$85K Hold
1,100
0.06% 66
2015
Q3
$77K Hold
1,100
0.06% 72
2015
Q2
$82K Hold
1,100
0.06% 52
2015
Q1
$86K Buy
+1,100
New +$83.4K 0.06% 72

Other funds holding MDT

Sharkey, Howes & Javer's MDT Position: Q3 2019 in Review

Sharkey, Howes & Javer sold out of Medtronic (MDT) in Q3 2019, closing a stake of 800 shares — an estimated $78K sold.

Sharkey, Howes & Javer first reported a position in MDT in Q1 2015 and held it in 18 quarters. The position peaked at $112K in Q3 2017. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Sharkey, Howes & Javer reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Sharkey, Howes & Javer sold 800 Medtronic shares in Q3 2019, an estimated $78K.
  • Sharkey, Howes & Javer first reported a position in Medtronic in Q1 2015 and held it in 18 quarters.
  • Sharkey, Howes & Javer's Medtronic position peaked at $112K in Q3 2017.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Sharkey, Howes & Javer's 13F filing for Q3 2019, filed 1 Nov 2019.